Article by Daniel Oberhaus, Vice
If Irvin Rosenfeld had to guess, he’d say he’s smoked about 135,000 joints since 1982—roughly ten a day, every day, for 34 years.
Despite a cannabis habit that would probably kill Snoop Dogg, the 63-year-old Floridian leads a fairly normal life: He’s a senior stockbroker at a large securities firm, who spends every Saturday volunteering with disabled adults and children, while grappling with a rare bone disease called multiple congenital cartilaginous exotosis.
When I called Rosenfeld at his office, he had just smoked one of the 300 pre-rolled joints the US government sends him every month as a patient in the FDA’s compassionateInvestigational New Drug (IND) program.
Rosenfeld’s government supplied stash is low potency—about 4 percent THC—and it doesn’t get him stoned. The choice, he told me, is not his. Ever since he first tried pot in the early 70s, he’s been unable to get high due to an anomaly with the cannabinoid receptors in his brain. Still, the cannabis takes the edge off of his chronic pain and, if you ask him, it’s the only reason he’s still alive.
When Rosenfeld was diagnosed with his disorder at age ten, the doctors found over 200 tumors covering his bones. These tumors were expected to multiply and grow, and in the meantime, Rosenfeld had to deal with the painful bone splinters the disorder causes.